NASDAQ:MRTX
Delisted

Mirati Therapeutics Stock News

etoro logo Buy MRTX
*Your capital is at risk
$58.70
+0 (+0%)
At Close: Apr 19, 2024
NEW YORK, NY / ACCESSWIRE / April 22, 2020 / Levi & Korsinsky announces it has commenced an investigation of Mirati Therapeutics, Inc. (NASDAQ:MRTX) concerning possible breaches of fiduciary duty. To
Mirati Therapeutics Inc (NASDAQ:MRTX) Director Craig A. Johnson sold 15,000 shares of the company’s stock in a transaction that occurred on Monday, April 20th. The shares were sold at an average pri
Mirati Therapeutics crumbled Tuesday after Kerrisdale Capital shorted MRTX stock on doubts surrounding the company's key cancer treatment. The drug would inhibit a known cancer driver.
Mirati’s KRAS inhibitor MRTX-849 will likely fail as a second line monotherapy in KRAS-mutant NSCLC. Consensus is emerging that Amgen’s AMG-510, with an identic
Mirati Therapeutics Inc (NASDAQ: MRTX) shares were seeing weakness Tuesday after short seller Kerrisdale Capital released a bleak report concerning its two investigational...
iQiyi put volume heavy and directionally bearish IQ
Onex upgraded to Outperform from Sector Perform at Scotiabank Scotiabank ONEXF
Inovio call volume above normal and directionally bullish INO
Alphabet ends talks for more Bay Area office space, The Information reports GOOG GOOGL
Qad Inc. participates in a conference call hosted by Sidoti QADA
GameStop put volume heavy and directionally bearish GME

Today's -8.5% U.S. existing home sales drop

03:07pm, Tuesday, 21'st Apr 2020
Today's -8.5% U.S. existing home sales drop
Treasury Action: risk aversion is putting a solid bid in Treasuries

FX Action: The dollar

03:07pm, Tuesday, 21'st Apr 2020
FX Action: The dollar
NY Governor Cuomo reports 481 virus deaths vs. 478 deaths the day before SPY SPX
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE